Your SlideShare is downloading. ×
0
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Pharmacodynamics   revised
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Pharmacodynamics revised

7,164

Published on

Published in: Education, Health & Medicine
1 Comment
6 Likes
Statistics
Notes
  • thank,its helping alot
       Reply 
    Are you sure you want to  Yes  No
    Your message goes here
No Downloads
Views
Total Views
7,164
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
196
Comments
1
Likes
6
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. General pharmacology By Mohamad-Hesham Daba,MD,PhD Associate professor of Clinical pharmacology
  • 2. Intended learning outcomes• Define pharmacodynamics• Recognise targets for drug actions• Classify drug receptors• Identify agonist, antagonist and partial ag• Describe graded and quantal dose response curves• Compare bet. affinity, potency and efficacy• Define therapeutic index• Discuss the clinical importance of drug combination
  • 3. Drug-body interactions• Pharmacodynamic interactions: the effects of the drugs on the body• Pharmacokinetic interactions: the way in which the body handles the drugs.
  • 4. PHARMACODYNAMICS• Mechanisms of drug action:• Body control systems:• Receptors• Ion channels• Enzymes• Carrier molecules
  • 5. Receptors• Definition:• Receptors are• protein macromolecules on the surface or within the cell• that combine chemically with small molecules (ligands)• and produces physiological regulatory functions.
  • 6. Membrane receptors
  • 7. Intracellular receptors
  • 8. • Ligand: is any molecule that can combine with the receptors. A ligand that activates the receptor is called agonist. A ligand that blocks the receptor is called antagonist.• Affinity: it is the empathy of the receptor to the ligand. It determines the ability of the drug to bind to receptors.• Efficacy: it is the ability of the drug to give certain Emax. It means the ability of the drug to induce effevt
  • 9. Agonist means a drug that activates thereceptors upon binding
  • 10. Pharmacologic antagonist:means a drug that binds without activating its receptors and thereby prevents activation by an agonistReceptor block may be:Reversible antagonism (Competitive antagonism)the antagonist effect can be overcome by increasing the concentration of agonistIrreversible antagonism (Non-competitive antagonism)the antagonist effect cannot be overcome by increasing the concentration of agonist
  • 11. Partial agonistmeans a drug that binds to its receptor butproduces a smaller effect at full dosage than a full agonist
  • 12. Dose response relationship curves and their importance• A. Graded dose-response• Importance: 1 Calculation of the ED50 - Potency - Equieffective doses - Relative sensitivity 2 Calculation of the Emax. - Efficacy (intrinsic activity)
  • 13. • Calculation of the ED50:• ED50 is the dose that produces 50% of the maximal response in one animal.• Value of knowing the ED50:• Comparing the potencies of multiple drugs.• Comparing the equieffective doses of multiple drugs.• Calculation of drug efficacy:• Efficacy is the maximal response (Emax) obtained by a drug.• Value of knowing the Emax:• Knowing the maximal responding capacity of the organ.• Differentiation between full agonists and partial agonists.
  • 14. • Potency versus efficacy:• ►Potency: it is the effect of drug in relation to its dose.• ►Efficacy: it is the ability of the drug to give certain Emax.• Efficacy is more important than potency because it is the major determinant of drug effectiveness while potency has little clinical importance because simply you can increase the dose of a less potent drug to obtain the effect of a more potent one (provided that it is not toxic)
  • 15. :B. Quantal dose-response curve• Importance:Calculation of the ED50 (the dose that gives specific effect in 50% of treated group of animals)Calculation of the LD50 (the dose that kills 50% of treated animals)Determination of the therapeutic index T.I.=LD50/ ED50 (it must be >1)
  • 16. • The therapeutic index (also known as therapeutic ratio) is a comparison of the amount of a therapeutic agent that causes the therapeutic effect to the amount that causes death (in animal studies) or toxicity (in human studies). So, in humans therapeutic index or ratio =TD50/ ED50
  • 17. Quick quiz1.Which branch of pharmacology studies the way drugs work in living organism?C. PharmacotherapeuticsD. PharmacokiniticsE. PharmacogeniticsF. PharmacodynamicsG. Pharmacovigilance
  • 18. Quick quiz• A 55-year-old woman with congestive heart failure is to be treated with a diuretic drug. Drugs X and Y have the same mechanism of diuretic action. Drug X in a dose of 5mg produces the same magnitude of diuresis as 500 mg of drug Y. This suggests that:A. Drug Y is less efficacious than drug X.B. Drug X is about 100 times more potent than drug Y.C. Toxicity of drug X is less than that of drug Y.D. Drug X is a safer drug than drug Y.E. Drug X will have a shorter duration of action than drug Y because less of drug X is present for a given effect.
  • 19. Quick quiz1. In the absence of other drug, pindolol causes an increase in heart rate by activating beta adrenoceptors. In the presence of highly effective beta stimulants, however, pindolol causes a dose-dependent, reversible decrease in heart rate. Therefore pindolol is probably:A. An irreversible antagonist.B. A physiologic antagonist.C. A chemical antagonist.D. A partial agonist.E. A Spare receptor agonist.
  • 20. Quick quiz1. Which of the following provides information about the variation in sensitivity to the drug within the population studied?A. Maximal efficacy.B. Therapeutic index.C. Drug potency.D. Graded dose-response curve.E. Quantal dose-response curve.
  • 21. Quick quiz5. Which of the following provides information about the largest response a drug can produces, regardless of dose?.A. Drug potency.B. Maximal efficacy.C. Mechanism of receptor action.D. Therapeutic index.E. Therapeutic window
  • 22. HYPOREACTIVITY TO DRUGS• Tolerance: decreased response to the same dose of the drug. The same response could be obtained by higher doses. It occurs over a long period• Tachyphylaxis: it is a type of tolerance, which occurs very rapidly.Probable mechanisms:• Change in receptors (desensitization):• Loss of receptors (down-regulation):• Exhaustion of mediators:• Increased metabolic degradation:• Physiological adaptation:
  • 23. HYPERREACTIVITY TO DRUGSovershoot phenomena or hypersusceptibility orintoleranceUp-regulation means increase number of receptorsdue to prolonged exposure to the antagonist orprolonged deficiency of the natural agonist. When theantagonist is suddenly withdrawn, severe reactionoccurs in the form of rebound or withdrawal effectse.g. severe tachycardia & arrhythmia can occur aftersudden stoppage of beta-blockers.
  • 24. DRUG COMBINATION• Summation and addition: combined effects of two drugs are equal to the sum of their individual effects.• Synergism or potentiation: combined effects of drugs may be greater than the sum of their individual effects.• Antagonism: - Chemical antagonism: - Physical antagonism: - Physiological antagonism: - Competitive antagonism: - Non-competitive antagonism
  • 25. • Which of the following terms best describes the antagonism of leukotriene’s bronchoconstrictor effect (mediated at leukotriene receptors) by terbutaline (acting at adrenoceptors) in a patient with asthma?2. Pharmacologic antagonist.3. Partial agonist.4. Physiologic antagonist.5. Chemical antagonist.6. Noncompetitive antagonist.
  • 26. • Many drugs produce effects by interaction with receptors. Other cellular components with which drugs interact to produce effects include:2. Nucleic acids.3. Structural proteins.4. Enzymes.5. Proteins involved in transport processes.6. All of the above.
  • 27. • Which of the following chemical compounds produce their major effects by binding to intracellular receptors that bind to nuclear DNA?2. Insulin.3. Succinylcholine.4. Catecholamines.5. Opioid peptides.6. Steroids.
  • 28. The term that refers to the rapid diminution of responsiveness following administration of a drug is:2.hyporeactivity3.idiosyncratic drug response4.tolerance5.drug inactivation6.tachyphylaxis
  • 29. MATCH the pharmacologic term in the answers below with the most :appropriate definition of the term in the items• Efficacy• Potency• Tolerance• Therapeutic index• IntoleranceA) Decreased response to the same dose of the drug.B) When the antagonist is suddenly withdrawn, severe reaction occurs in the form of rebound or withdrawal effectsC) This is the maximal response obtainable by a drug treatmentD) This is the ratio of the toxic dose to the therapeutic doseE) This is the amount of drug required to produce a desired effect

×